Investment

Jim Simons’ investment office backs fast-growing biotech unicorn

A rapidly growing biotech group that listed on NASDAQ last month with a market capitalisation of more than a billion dollars is backed by Euclidean Capital, the investment office of hedge fund legend, Jim Simons.

Subscribe

You will need a Premium+ Subscription to read this article.

Exclusive news, analysis and research on global family enterprise and private investment offices

SUBSCRIBE TODAY

Already have an account? Sign in

You need a Premium subscription.

To read Premium articles please subscribe.

SUBSCRIBE TODAY

Already have an account? Sign in

You've reached the end.

Continue reading free articles by registering as a Member.
Or choose a Premium Plan.

SUBSCRIBE TODAY

Already have an account? Sign in

What to read next

Investment

A Californian-based family office has bought a stake in an agribusiness that is also one of the biggest landowners in an area north of Los Angeles
Investment

This week, there were several big investments, including an investment vehicle owned by one of the Nordic region’s wealthiest investors backing a farming group and a Portuguese family office investing i…
Investment

A US family office is set to buy a stake in the world’s top rugby national side, beating private equity funds to the deal and further underlining the increasing relationship between top sports teams a…

Leave a Reply